PAVmed (PAVM) director gets 13,930-share restricted stock grant

Rhea-AI Filing Summary

Sparks Ronald M reported acquisition or exercise transactions in this Form 4 filing.

PAVmed Inc. director Ronald M. Sparks received a grant of 13,930 shares of common stock as restricted stock under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. The award has a single vesting date of May 20, 2029 and is subject to forfeiture if the required service period is not completed. Following this grant, Sparks directly holds 21,097 shares of PAVmed common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sparks Ronald M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock	13,930	$0.00	--

Holdings After Transaction: Common stock — 21,097 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock granted: 13,930 shares Holdings after transaction: 21,097 shares Vesting date: May 20, 2029 +1 more

4 metrics

Restricted stock granted 13,930 shares Award of PAVmed common stock to director Ronald M. Sparks

Holdings after transaction 21,097 shares Direct PAVmed common stock held by Ronald M. Sparks post-grant

Vesting date May 20, 2029 Single vesting date for the restricted stock award

Reported price per share $0.00 per share Stated transaction price for the restricted stock grant

Key Terms

restricted stock, Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, vesting date, forfeiture, +1 more

5 terms

restricted stock financial

"Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan financial

"granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

vesting date financial

"with a single vesting date of May 20, 2029"

forfeiture financial

"Such restricted stock is subject to forfeiture if the requisite service period is not completed"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sparks Ronald M

(Last) (First) (Middle)

360 MADISON AVENUE

25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	04/02/2026		A		13,930(1)	A	$0	21,097	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon, by power of attorney	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PAVmed (PAVM) director Ronald M. Sparks report in this Form 4?

Ronald M. Sparks reported receiving 13,930 shares of PAVmed common stock as a restricted stock grant. The award was issued under the company’s long-term incentive equity plan and increased his direct holdings to 21,097 common shares after the transaction.

How many PAVmed (PAVM) shares were granted to Ronald M. Sparks?

Ronald M. Sparks was granted 13,930 shares of PAVmed common stock as restricted stock. The filing shows these shares were awarded at a stated price of $0.00 per share as part of equity compensation rather than an open-market purchase.

When do Ronald M. Sparks’ restricted PAVmed (PAVM) shares vest?

The restricted stock granted to Ronald M. Sparks has a single vesting date of May 20, 2029. According to the filing, the shares are subject to forfeiture if he does not complete the requisite service period through that vesting date.

What are Ronald M. Sparks’ PAVmed (PAVM) holdings after this grant?

After receiving the restricted stock award, Ronald M. Sparks directly holds 21,097 shares of PAVmed common stock. This figure reflects his position immediately following the reported Form 4 transaction and includes the newly granted restricted shares.

Is Ronald M. Sparks’ PAVmed (PAVM) stock grant an open-market purchase?

No, the filing classifies the transaction as a grant or award acquisition of common stock, not an open-market purchase. The transaction price per share is reported as $0.00, indicating equity compensation under PAVmed’s long-term incentive equity plan.

What conditions apply to Ronald M. Sparks’ PAVmed (PAVM) restricted stock?

The restricted stock is subject to forfeiture if the requisite service period is not completed. It vests on a single date, May 20, 2029, under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, as disclosed in the footnote.